Biotech

All Articles

Eli Lilly opens $700M nucleic acid R&ampD center in Boston Port

.Eli Lilly has opened up a $700 thousand R&ampD center in the Boston ma Seaport, enhancing its own R...

Boundless Biography produces 'moderate' layoffs 5 months after $100M IPO

.Simply 5 months after safeguarding a $100 thousand IPO, Boundless Bio is actually presently laying ...

Halda's $126M will definitely accelerate 'hold as well as eliminate' lump medicines

.The preliminary phases of oncology R&ampD aren't except interesting brand new modalities, as well a...

Lykos 'remorses' certainly not making known research offenses with publisher

.Psychopharmacology has drawn 3 posts concerning midstage medical trial information analyzing Lykos ...

Analysts go into Avidity's DMD gain, uncovering nuances in information

.Avidity Biosciences amazed entrepreneurs with phase 1/2 records in Duchenne muscle dystrophy (DMD) ...

Actinogen's cortisol blocker neglects phase 2 anxiety research study

.Actinogen Medical's cortisol blocker has actually missed the major endpoint of a period 2 study in ...

Bivictrix decides going exclusive only way to take ADC right into center

.Antibody-drug conjugates (ADCs) have been at the center of lots of a billion-dollar biobuck licensi...

TPG tops up funds to $580M for investments throughout life sciences

.Asset manager TPG, which has actually sustained biotechs such as Sionna Rehabs and Santa Clam Ana B...

Merck stops period 3 TIGIT trial in lung cancer for impossibility

.Merck &amp Co.'s TIGIT program has actually suffered yet another drawback. Months after shuttering ...

After a difficult year, Exscientia folds up right into Recursion

.After a year specified by pipe hairstyles, the shift of its chief executive officer and unemploymen...